key: cord-0975902-tj7zwbvc authors: Mir, Tajamul H.; Zargar, Parvaiz A.; Jabeen, Bushra; Zahoor, Aariba title: Nicorandil a magic bullet or a double edged sword in critically ill COVID‐19 patients? date: 2021-03-08 journal: Clin Exp Pharmacol Physiol DOI: 10.1111/1440-1681.13487 sha: 05914e5f97b28f898109a4fd16e3ae4346f2cfcf doc_id: 975902 cord_uid: tj7zwbvc nan Given the setting of an acute illness especially associated with SIRS like picture, the risk of hyperkalemia with nicorandil is very high since multiple players operate synergistically to cause activation of potassium channels with the added influence of the drug in sustaining that state of K + ATP channel activation and its deadly consequences. In SIRS and sepsis since K + ATP channels are already upregulated, experts have even considered the need for novel potassium channel blockers to mitigate hypotension. Therefore, theoretically speaking even if nicorandil is to be used in critically ill COVID-19 patients as suggested by the authors, higher doses and intravenous infusions would possibly be required to offset the inflammatory and thrombotic cascades which would mean a higher risk of life-threatening hyperkalemia. Just based on a few in vitro experimental studies and translating them into the immediate clinical use of nicorandil for blunting the complex inflammatory onslaught and an overwhelming thrombosis and lung fibrosis in critically ill COVID-19 patients could be detrimental. Its anti-inflammatory, antithrombotic and antifibrotic benefits could be far outweighed by its predominant pharmacological Hypothesis: the potential therapeutic role of nicorandil in COVID-19 patients Sinus arrest and severe peripheral vasodilation following cardiopulmonary bypass in a patient taking nicorandil An updated review of its use in Ischaemic heart disease with emphasis on its cardio protective effects Potassium channels: molecular defects, diseases, and therapeutic opportunities Mitochondrial potassium ATP channels and retinal ischemic preconditioning Role of KATP channels in sepsis Nicorandil-induced hyperkalemia in a uremic patient Intractable hyperkalemia due to nicorandil induced potassium channel syndrome Nicorandil-induced hyperkalemia in a hemodialysis patient Reversal of life threatening, drug-related potassium-channel syndrome by glibenclamide https://orcid.org/0000-0003-0764-7520